Preoperatif Anestezik Değerlendirme
Synopsis
The management of cesarean and delivery anesthesia must be planned in advance by a multidisciplinary team based on the condition of the pregnant woman and the fetus, and since every delivery carries the potential for an emergency cesarean section, antenatal anesthesia consultation should be conducted in a timely manner for high-risk pregnant women. The primary goal of antenatal evaluation is to identify risk factors such as airway problems, cardiac diseases, obesity, coagulopathy, or neurological conditions to establish a safe intrapartum and postpartum anesthesia plan and to reduce maternal morbidity and mortality. During the preoperative period, a detailed history and physical examination of the patient must be performed, evaluating the airway, cardiovascular, and respiratory systems, as well as suitability for neuraxial block. Early recognition and preparation are vital because physiological changes during pregnancy increase the risk of a difficult airway. For elective cases, a fasting period of 2 hours for clear liquids and 6–8 hours for solid food is recommended, whereas stricter restrictions and aspiration prophylaxis should be applied to patients at high risk of aspiration. In pregnant women with respiratory disease or asthma, pulmonary reserves should be determined, and high-dose morphine, which may cause histamine release, as well as NSAIDs, which may trigger asthma, should be avoided. Pregnant women with heart disease should be evaluated using NYHA, ZAHARA, CARPREG I–II, and modified WHO risk classifications to determine cardiac risk, and high-risk patients should be followed up and delivered using a multidisciplinary approach in tertiary centers equipped with specialized cardiology and anesthesia units.
References
Tsen LC, Bateman BT. Anesthesia for Cesarean Delivery in Chestnut's Obstetric Anesthesia, Sixth Edition. Elsevier. 2020. 568-626
Arendt KW, Lindley KJ. Obstetric anesthesia management of the patient with cardiac disease. Int J Obstet Anesth. 2019 Feb;37:73-85.
Silversides CK, Grewal J, Mason J, et al. Pregnancy Outcomes in Women With Heart Disease: The CARPREG II Study. J Am Coll Cardiol. 2018;71:2419-2430
Lockhart EM, Hincker A, Klumpner TT, et al. Consultation, Surveillance, Monitoring, and Intensive Care (COSMIC): A Novel 4-Tier Program to Identify and Monitor High-Risk Obstetric Patients From the Clinic to Critical Care. Anesth Analg. 2019;128(6):1354-1360.
Practice Guidelines for Obstetric Anesthesia: An Updated Report by the American Society of Anesthesiologists Task Force on Obstetric Anesthesia and the Society for Obstetric Anesthesia and Perinatology. Anesthesiology. 2016;124(2):270-300.
Munnur U, Suresh MS. Airway problems in pregnancy. Crit Care Clin. 2004 Oct;20(4):617-42
Hinova A, Fernando R. The preoperative assessment of obstetric patients. Best Pract Res Clin Obstet Gynaecol. 2010 Jun;24(3):261-76. doi: 10.1016/j.bpobgyn.2009.12.003. Epub 2010 Jan 4.
Practice guidelines for preoperative fasting and the use of pharmacologic agents to reduce the risk of pulmonary aspiration: An updated report by the American Society of Anesthesiologists Task Force on Preoperative Fasting. Anesthesiology 2011; 114:495–511.
Liu S, Wen SW, Demissie K, Marcoux S, Kramer MS. Maternal asthma and pregnancy outcomes: a retrospective cohort study. Am J Obstet Gynecol. 2001 Jan;184(2):90-6. doi: 10.1067/mob.2001.108073. PMID: 11174486.
Mertes PM & Laxenaire MC. Allergic reactions occurring during anaesthesia.Eur J Anaesthesiol. 2002;19:240–262
Rouse DJ, MacPherson C, Landon M, et al, National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network. Blood transfusion and cesarean delivery. Obstet Gynecol. 2006 Oct;108(4):891-7.
Yancy CW, Jessup M, Bozkurt B, et al. 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation. 2013;128:e240–e327.
Siu SC, Sermer M, Colman JM et al. Prospective multicenter study of pregnancy outcomes in women with heart disease.Circulation. 2001;104:515–521.
Drenthen W, Boersma E, Balci A, et al; ZAHARA Investigators. Predictors of pregnancy complications in women with congenital heart disease. Eur Heart J. 2010 Sep;31(17):2124-32.
Thorne S, MacGregor A, Nelson-Piercy C. Risks of contraception and pregnancy in heart disease. Heart. 2006 Oct;92(10):1520-5.
Balci A, Sollie-Szarynska KM, van der Bijl AG, et al; ZAHARA-II investigators. Prospective validation and assessment of cardiovascular and offspring risk models for pregnant women with congenital heart disease. Heart. 2014 Sep;100(17):1373-81.
Regitz-Zagrosek V, Roos-Hesselink JW, Bauersachs J, et al. 2018 ESC guidelines on the management of cardiovascular diseases during pregnancy. Eur Heart J. 2018;39:3165–3241.